Testing and validating an e-health (smartphone application) approach to better understand the determinants of day-to-day symptomatology in depression, medication adherence, and treatment efficacy in the goal of maximizing patient care.
Age between 18 and 65 years;
Fulfilling the Diagnostic and Statistical Manual version IV (DSM-IV) criteria of depression assessed by the Structured Clinical Interview;
Patients started their antidepressant treatment less than 5 days before inclusion;
Patient treated in an outpatient setting;
A current mental or psychiatric impairment or disease (schizophrenia, bipolar disorder) that required psychotropic medication or inpatient treatment on a psychiatric ward;
A history of psychosis, including schizophrenia, bipolar I or bipolar II disorder, and major depressive disorder with psychotic features;
Cognitive deficit and not thus being able to comprehend the informed consent and study procedure;
Patients with somatic, cognitive or other disorders preventing the use of the device (deafness, impaired vision, illiteracy….);
Parallel
Smartphone Support System
Device6 weeks smartphone application with daily evaluations
A greater clinical response in the active group (smartphone application) comparatively to the comparator group (clinical response was defined as a decline in HDRS-17 score greater than 50%)
HDRS Hamilton Depressive Rating Scale. Changes in HDRS scores of at least 50% at 8 weeks.
Improvement in scores for therapeutic alliance
Measurement by the 4PAS (4-Point Ordinal Alliance Self-Report)
Improvement in scores for medication adherence
Measurement by the MARS (Medical Adherence Rating Scale)
Improvement in scores for Quality of Life
Measurement by the Q-LES-Q-SF (Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form)
Click on the lead sponsor to view all of their trials.
